GeneMe
Private Company
Total funding raised: $1.5M
Overview
GeneMe is a Warsaw-based genetic diagnostics company providing personalized DNA analysis services directly to consumers. Operating since 2015, it leverages genetic testing to offer health predisposition, wellness, and ancestry reports, positioning itself in the growing European personalized medicine market. As a private entity, it likely follows a service-based revenue model, selling test kits and reports. The company's success hinges on its testing accuracy, data interpretation, marketing reach, and ability to navigate the evolving regulatory landscape for genetic data.
Technology Platform
DNA genotyping via microarray and bioinformatic analysis pipeline for interpreting genetic variants related to health, wellness, and ancestry.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
GeneMe operates in a highly competitive DTC genetic testing market, competing against global giants like 23andMe and AncestryDNA, as well as other European players like MyHeritage and numerous local diagnostics labs. Differentiation is key and may be achieved through local market expertise, Polish-language support, and tailored reporting for the regional population.